ABN AMRO Bank N.V. Decreases Stock Holdings in Ventas, Inc. $VTR

Key Points

• ABN AMRO Bank N.V. reduced its Ventas stake by 11.1% in the fourth quarter, selling 12,765 shares and leaving it with 101,815 shares worth about $7.9 million.
• Ventas reported Q1 earnings of $0.11 per share, missing estimates by a penny, but revenue came in above expectations at $1.65 billion and rose 22% year over year.
• Analyst sentiment remains constructive, with a Moderate Buy consensus and a target price of $93.50; several firms recently raised price targets, including RBC to $98 and UBS/Wells Fargo to $93.

ABN AMRO Bank N.V. trimmed its stake in shares of Ventas, Inc. (NYSE:VTR - Free Report) by 11.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 101,815 shares of the real estate investment trust's stock after selling 12,765 shares during the period. ABN AMRO Bank N.V.'s holdings in Ventas were worth $7,911,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. GoalVest Advisory LLC purchased a new stake in Ventas during the fourth quarter valued at approximately $26,000. Cloud Capital Management LLC purchased a new stake in Ventas during the third quarter valued at approximately $25,000. Wiser Advisor Group LLC purchased a new stake in Ventas during the third quarter valued at approximately $27,000. Wilmington Savings Fund Society FSB increased its holdings in Ventas by 65.5% during the third quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust's stock valued at $32,000 after buying an additional 180 shares during the last quarter. Finally, ORG Partners LLC increased its holdings in Ventas by 76.1% during the third quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust's stock valued at $32,000 after buying an additional 197 shares during the last quarter. 94.18% of the stock is owned by hedge funds and other institutional investors.

Ventas Stock Performance

VTR opened at $87.26 on Monday. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.25 and a quick ratio of 0.25. The company has a 50 day simple moving average of $84.81 and a two-hundred day simple moving average of $80.56. Ventas, Inc. has a 1-year low of $61.76 and a 1-year high of $88.50. The firm has a market cap of $42.42 billion, a P/E ratio of 158.66, a PEG ratio of 2.15 and a beta of 0.74.

Ventas (NYSE:VTR - Get Free Report) last issued its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts' consensus estimates of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the prior year, the company posted $0.84 EPS. Ventas's revenue was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Equities analysts forecast that Ventas, Inc. will post 3.85 earnings per share for the current fiscal year.

Insider Buying and Selling at Ventas

In related news, EVP Carey S. Roberts sold 35,532 shares of the company's stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the completion of the transaction, the executive vice president owned 72,755 shares in the company, valued at approximately $6,184,175. This represents a 32.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.53% of the company's stock.

Analyst Ratings Changes

A number of analysts have commented on VTR shares. Argus set a $88.00 target price on shares of Ventas in a report on Tuesday, February 10th. Wells Fargo & Company upped their target price on shares of Ventas from $88.00 to $93.00 and gave the company an "overweight" rating in a report on Thursday, March 26th. UBS Group upped their target price on shares of Ventas from $85.00 to $93.00 and gave the company a "neutral" rating in a report on Monday, May 4th. Royal Bank Of Canada upped their target price on shares of Ventas from $91.00 to $98.00 and gave the company an "outperform" rating in a report on Monday, May 4th. Finally, Morgan Stanley set a $90.00 target price on shares of Ventas in a report on Friday, February 13th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $93.50.

Ventas Profile

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.